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Na/K-ATPase signaling has been implicated in different physiological and
pathophysiological conditions. Accumulating evidence indicates that oxidative stress not
only regulates the Na/K-ATPase enzymatic activity, but also regulates its signaling and
other functions. While cardiotonic steroids (CTS)-induced increase in reactive oxygen
species (ROS) generation is an intermediate step in CTS-mediated Na/K-ATPase
signaling, increase in ROS alone also stimulates Na/K-ATPase signaling. Based on
literature and our observations, we hypothesize that ROS have biphasic effects on
Na/K-ATPase signaling, transcellular sodium transport, and urinary sodium excretion.
Oxidative modulation, in particular site specific carbonylation of the Na/K-ATPase α1
subunit, is a critical step in proximal tubular Na/K-ATPase signaling and decreased
transcellular sodium transport leading to increases in urinary sodium excretion. However,
once this system is overstimulated, the signaling, and associated changes in sodium
excretion are blunted. This review aims to evaluate ROS-mediated carbonylation of the
Na/K-ATPase, and its potential role in the regulation of pump signaling and sodium
reabsorption in the renal proximal tubule (RPT).
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Accumulating evidence suggests that excessive dietary salt intake may play a role in the
pathogenesis of hypertension, with more pronounced effects seen in salt-sensitive patients
(Calhoun et al., 2008). Consequently, modest restriction of dietary salt and diuretic therapy are
often recommended for treatment of resistant hypertension, particularly within the salt-sensitive
sub-group (He and MacGregor, 2004; Calhoun et al., 2008). Long-term blood pressure (BP)
regulation is highly associated with renal sodium handling (Guyton, 1991). Recent studies observe
the CTS-activated Na/K-ATPase signaling pathway to contribute to RPT sodium handling and salt
sensitivity (Buckalew, 2005; Meneton et al., 2005; Schoner and Scheiner-Bobis, 2007, 2008; Bagrov
and Shapiro, 2008; Fedorova et al., 2010; Liu and Xie, 2010). Various intercellular and extracellular
functions are regulated by the signaling function of the Na/K-ATPase. Discussion of Na/K-ATPase
signaling and the downstream physiological and pathophysiological implications can be found in
several references (Bertorello and Sznajder, 2005; Buckalew, 2005; Aperia, 2007; Liu and Shapiro,
2007; Schoner and Scheiner-Bobis, 2007, 2008; Bagrov and Shapiro, 2008; Bagrov et al., 2009;
Blaustein et al., 2009; Li and Xie, 2009; Fedorova et al., 2010; Liu and Xie, 2010). Based on our recent
observations, we focus on the effect of oxidative (carbonylation) modification of Na/K-ATPase and
sodium handling in RPTs.
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PROTEIN CARBONYLATION AND CELL
SIGNALING
Biologically, electron reduction of oxygen (O2) leads to
generation of ROS including superoxide (O−2 ), hydrogen
peroxide (H2O2), and hydroxyl radical (HO
›). ROS is able
to oxidize various types of biological molecules including
proteins, lipids, and DNA, leading to their functional changes.
Through Fenton’s reaction, H2O2 (generated by O
−
2 or via other
mechanisms) is reduced to HO› by coupling oxidation of reduced
ferrous ion (Fe2+) to ferric ion (Fe3+). This metal-catalyzed
oxidation (MCO) process oxidizes proteins by introducing
carbonyl groups (such as aldehydes, ketones, or lactams) into
the side chains of certain amino acids (such as proline,
arginine, lysine and threonine; Stadtman and Berlett, 1991;
Stadtman and Levine, 2000; Nyström, 2005). Unlike this direct
(primary) carbonylation, indirect (secondary) carbonylation on
lysine, cysteine, and histidine can occur by reactive carbonyl
compounds generated from other types of oxidation, such as
lipid and carbohydrate oxidation via Michael addition reactions
and formation of Schiff bases. Protein carbonylation is a well-
recognized marker of oxidative stress because of its stability, its
effect on protein functions, and its link to various biological and
pathological conditions. Oxidative stress has been implicated in
the aging process, various conditions like ischemia-reperfusion
and hyperoxia, and various human diseases like Alzheimer’s
disease, chronic lung disease, chronic renal failure, diabetes, and
sepsis (Stadtman and Levine, 2000; Dalle-Donne et al., 2003,
2006a,b). Since the Fenton reaction involves the conversion of
H2O2 to HO
•, any specie of ROS with H2O2 as an intermediate
and/or end product may stimulate the reaction. In biological
systems, H2O2 is one of the most common end products of most
ROS generating systems.
Oxidative modification of protein, reversible and irreversible,
dynamically regulates protein structure, function, and trafficking,
as well as cellular signaling and function (Go and Jones, 2013).
Direct protein carbonylation is very stable and “chemically”
irreversible (Stadtman and Berlett, 1991; Nyström, 2005). Recent
studies from the Suzuki laboratory have demonstrated the
role of the carbonylation/decarbonylation process in ROS
signal transduction in which thiol groups were responsible
for decarbonylation via enzymatic processes, likely through
thioredoxin reductase (Wong et al., 2008, 2010, 2012, 2013).
CTS, THE NA/K-ATPASE, AND RENAL
SODIUM HANDLING
CTS, also known as endogenous digitalis-like substances, include
plant-derived glycosides and vertebrate-derived aglycones
(Schoner and Scheiner-Bobis, 2007, 2008). Although, the
production and secretion of endogenous CTS are not completely
understood, they appear to be regulated by angiotensin II and
adrenocorticotropic hormone (Hamlyn et al., 1991; Laredo
et al., 1997; Schoner and Scheiner-Bobis, 2007; Bagrov et al.,
2009). CTS are present in measurable amounts under normal
physiological conditions, and are elevated under a number of
pathological states. Different species of endogenous CTS show
variations in kinetics and tissue action in response to salt loading
in both animal models and in human hypertensive patients
(Haddy and Pamnani, 1998; Fedorova et al., 2005; Manunta et al.,
2006; Schoner and Scheiner-Bobis, 2007, 2008).
The Na/K-ATPase belongs to the P-type ATPase family and
consists of two non-covalently linked α and β subunits. Several
α and β isoforms, expressed in a tissue-specific manner, have
been identified and functionally characterized (Sweadner, 1989;
Blanco and Mercer, 1998; Kaplan, 2002; Sanchez et al., 2006).
The α1 subunit contains multiple structural motifs that interact
with soluble, membrane and structural proteins (Jordan et al.,
1995; Beggah and Geering, 1997; Feschenko et al., 1997; Zhang
et al., 1998, 2006a; Yudowski et al., 2000; Lee et al., 2001; Xie and
Cai, 2003; Barwe et al., 2005; Song et al., 2006; Tian et al., 2006).
Binding to these proteins not only regulates the ion pumping
function of the enzyme, but it also conveys signal transducing
functions to the Na/K-ATPase (Xie and Cai, 2003; Kaplan, 2005;
Kaunitz, 2006; Schoner and Scheiner-Bobis, 2007; Li and Xie,
2009).
It has been hypothesized for years that increases in
endogenous CTS enhance natriuresis and diuresis by direct
inhibition of renal tubular Na/K-ATPase, leading to reduced
renal reabsorption of filtered sodium (Blaustein, 1977; Haddy
et al., 1979; de Wardener and Clarkson, 1985). The first
unequivocal demonstration of ouabain-like substance in human
plasma was reported 25 years ago (Hamlyn et al., 1991). In
vivo experiments suggest the essential role of endogenous CTS
in modulating renal sodium excretion and BP with different
approaches. First, administration of some (e.g., ouabain) but
not all CTS induces natriuresis (Foulkes et al., 1992; Yates
and McDougall, 1995). Second, in transgenic mice expressing
ouabain-sensitive Na/K-ATPase α1 subunit, both acute salt load
and ouabain infusion augment natriuretic responses, which may
be inhibited by administration of an anti-digoxin antibody
fragment (Dostanic-Larson et al., 2005; Loreaux et al., 2008).
Third, immune-neutralization of endogenous CTS prevents CTS
mediated natriuretic and vasoconstrictor effects (Fedorova et al.,
2001, 2002; Bagrov and Shapiro, 2008; Nesher et al., 2009).
Fourth, administration of the ouabain-antagonist, rostafuroxin
(previously PST 2238) not only prevents ouabain induced Na/K-
ATPase signaling, but also prevents ouabain-induced increase in
BP (Ferrandi et al., 2004). Finally, in humans, high salt intake
increases circulating endogenous CTS (Manunta et al., 2006;
Anderson et al., 2008; Bagrov and Shapiro, 2008). Increased CTS
excretion is directly linked to enhanced RPT-mediated fractional
Na+ excretion, but inversely related to age and to age-dependent
increase in salt-sensitivity (Anderson et al., 2008).
THE NA/K-ATPASE SIGNALING AND SALT
SENSITIVITY
Although historical focus has largely been on the direct
inhibition of the Na/K-ATPase ion-exchange activity and sodium
reabsorption in RPTs by CTS, this does not appear to be
the predominant mechanism for several reasons. In contrast,
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the newly appreciated signaling function of Na/K-ATPase has
been widely confirmed and provides a realistic, mechanistic
framework that we will discuss further. We have observed that
the renal Na/K-ATPase and its signaling play a key role in
regulating renal sodium handling (Liu et al., 2002, 2004, 2005,
2011; Periyasamy et al., 2005; Oweis et al., 2006; Cai et al., 2008;
Yan et al., 2013).
Decreases in basolateral Na/K-ATPase activity alone do not
appear sufficient to decrease net sodium reabsorption across
the renal tubular epithelium. In porcine RPT LLC-PK1 cells,
ouabain activates the Na/K-ATPase signaling pathways and
consequently redistributes the basolateral Na/K-ATPase and
the apical sodium/hydrogen exchanger isoform 3 (NHE3) in
a coordinated manner; this leads to symmetrical reduction of
cell surface Na/K-ATPase and NHE3 expression, and ultimately
decreases net transcellular sodium transport (Liu et al., 2002,
2004, 2005; Oweis et al., 2006; Cai et al., 2008; Figure 1). In this
experimental model, the concentrations of ouabain used in vitro
were chosen to mimic the concentrations of CTS seen in vivo
with salt loading. No significant acute change in intracellular Na+
concentration was observed (Cai et al., 2008), further suggesting
the coordination of the downregulation of both apical and
basolateral sodium transporters. This Na/K-ATPase signaling
mediated regulation of renal tubular epithelial ion transporters
was additionally confirmed in in vivo studies (Periyasamy et al.,
2005; Liu et al., 2011).
The Dahl salt-resistant (R) and salt-sensitive (S) strains
were developed from Sprague Dawley rat strain by selective
breeding, depending on the resistance or susceptibility to the
hypertensive effects of high dietary sodium (Dahl et al., 1962).
In these strains, sodium handling within the RPT is an essential
determinant of their different BP responses (Dahl et al., 1974;
Rapp, 1982; Rapp and Dene, 1985; Mokry and Cuppen, 2008).
At the cost of elevated systolic BP, Dahl S rats rid excess
sodium primarily via pressure-natriuresis. In contrast, Dahl R
rats counterbalance salt loading via significant reduction of renal
sodium reabsorption without increasing BP. In vivo studies
indicate that impaired RPT Na/K-ATPase signaling appears to be
causative of experimental Dahl salt-sensitivity (Liu et al., 2011).
Specifically, in Dahl R rats (Jr strain), a high salt diet (2% NaCl
for 7 days) and exposure to ouabain activates RPT Na/K-ATPase
signaling and stimulates coordinated redistribution of Na/K-
ATPase and NHE3, resulting with increases in renal sodium
excretion. However, this does not occur in age- and gender-
matched Dahl S rats (Jr strain; Liu et al., 2011). At present,
we do not have a simple explanation for this occurrence. First,
the α1 subunit is essentially the only α isoform expressed in
RPTs (Blanco and Mercer, 1998; Summa et al., 2004) and genes
coding α1 subunit and NHE3 (in rat chromosomes 1 and 2,
respectively) are not located in identified and proposed BP
quantitative trait loci (Joe, 2006). Second, there is no difference
in α1 gene (Atp1a1) coding (Mokry and Cuppen, 2008), α1
ouabain-sensitivity (Nishi et al., 1993), and α1 expression (Liu
et al., 2011) between these two strains. Third, acute salt-loading
increases circulating CTS (ouabain and MBG) in both S and
R rats (Fedorova et al., 2000). These observations suggest that
there must be resistance to CTS signaling in the Dahl S rat, a
phenomenon that we only partially understand and will discuss
further below.
ROS AND THE NA/K-ATPASE SIGNALING
It is well established that an increase in oxidative stress occurs
in many forms of experimental hypertension (Kitiyakara et al.,
2003; Touyz, 2004; Wilcox, 2005; Vaziri and Rodriguez-Iturbe,
2006; Welch, 2006). We and others have observed that a high
salt diet stimulates endogenous CTS release and ROS generation
within the RPT (Moe et al., 1991; Yang et al., 2008; Panico
et al., 2009; McDonough, 2010; Banday and Lokhandwala,
2011; Liu et al., 2011). The increases in ROS (Meng et al.,
2002; Kitiyakara et al., 2003; Taylor et al., 2006) regulate
physiological processes including renal tubular ion transport,
fluid reabsorption, and sodium excretion (Moe et al., 1991; Zhang
et al., 2002; Garvin and Ortiz, 2003; Han et al., 2005; Yang
et al., 2008; Panico et al., 2009; Wang et al., 2009; Banday and
Lokhandwala, 2011; Liu et al., 2011; Schreck and O’Connor,
2011). In particular, increases in ROS regulate the activity and
cellular distribution of the basolateral Na/K-ATPase as well as the
apical NHE3 and sodium/glucose cotransporter, at least under
normal circumstances (Moe et al., 1991; Fisher et al., 2001; Silva
and Soares-da-Silva, 2007; Yang et al., 2007, 2008; Panico et al.,
2009; Crajoinas et al., 2010; Johns et al., 2010; Liu et al., 2011).
In our in vitro studies with LLC-PK1 cells, we have observed
that ouabain stimulates generation of ROS which is critical in
CTS-mediated Na/K-ATPase signaling, transporter trafficking,
and 22Na+ flux (Yan et al., 2013). Pre-treatment with higher
doses, but not a low dose, of anti-oxidant N-acetyl-L-cysteine
(NAC) attenuated the effect of ouabain on c-Src activation and
transcellular 22Na+ flux, suggesting a role of basal physiological
redox status in the initiation of ouabain induced Na/K-ATPase
signaling. This is analogous to the observation that the Na/K-
ATPase activity is redox-sensitive with an “optimal redox
potential range” (Petrushanko et al., 2006). While CTS stimulates
ROS generation and Na/K-ATPase signaling in different in
vitro and in vivo models (Xie et al., 1999; Liu et al., 2000,
2006; Tian et al., 2003; Kennedy et al., 2006a,b; Elkareh et al.,
2007), glucose oxidase-induced H2O2 alone also stimulates
Na/K-ATPase signaling, promotes Na/K-ATPase endocytosis,
and inhibits active transcellular 22Na+ transport (Liu et al.,
2006; Yan et al., 2013). The phenomenon of redox-sensitivity
of the Na/K-ATPase has been demonstrated within many
animal species, tissues, and cell types. Oxidative modification
can affect Na/K-ATPase activity through different mechanisms.
For example, S-glutathionylation is the formation of a mixed
disulphide (cysteine-S-S-glutathione) between cysteine-SH with
glutathione-SH or thiol-disulfide exchange. S-glutathionylation
of cysteine residue(s) of the Na/K-ATPase α subunit can
block the intracellular ATP-binding site, leading to inhibition
of its enzymatic activity (Petrushanko et al., 2012). Ouabain-
induced S-glutathionylation of cysteine of the Na/K-ATPase
β1 subunit, a process affected by Na/K-ATPase conformational
poise (Liu et al., 2012), reduces α1/β1 association and enzymatic
activity by stabilizing the enzyme in an E2-prone conformation
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FIGURE 1 | Schematic illustration of CTS and ROS mediated sodium handling in RPT and its relation to salt sensitivity. CTS induced intracellular ROS
generation and extracellularly generated ROS stimulates Na/K-ATPase/c-Src signaling, protein carbonylation, and transporter redistribution. Pretreatment with NAC
blocks this process. ROS1, CTS induced intracellular ROS generation through Na/K-ATPase signaling; ROS2, extracellular ROS generated by glucose oxidase or
other stimuli. Please also see Figure 2. RPT, renal proximal tubule; NAC, N-acetyl-L-cysteine.
(Figtree et al., 2009). Oxidants and oxidative modification of
the Na/K-ATPase can lead to functional changes (Kim and
Akera, 1987; Xie et al., 1990; Huang et al., 1992; Mense
et al., 1997; Thevenod and Friedmann, 1999; Zhang et al.,
2002; Ellis et al., 2003; Bogdanova et al., 2006; Liu et al.,
2006; Reifenberger et al., 2008; Blaustein et al., 2009; Figtree
et al., 2009; White et al., 2009; Bibert et al., 2011; Figtree
et al., 2012; Petrushanko et al., 2012; Soares-da-Silva, 2012) and
formation of Na/K-ATPase oligomeric structure (Dobrota et al.,
1999). As partner of Na/K-ATPase signaling, tyrosine kinase
c-Src and lipid rafts (including caveolae structural component
caveolins) are also redox-sensitive and critical in redox signaling
platform formation (Seshiah et al., 2002; Zuo et al., 2005; Touyz,
2006; Zhang et al., 2006b; Han et al., 2008). This suggests a
redox-sensitive Na/K-ATPase signaling and its possible role in
ROS regulation.
Both ouabain and glucose oxidase-induced H2O2 stimulate
Na/K-ATPase signaling and neutralization of the increase in ROS
attenuated ouabain-induced effects (Xie et al., 1999; Liu et al.,
2000, 2006; Tian et al., 2003; Kennedy et al., 2006a; Elkareh et al.,
2007; Yan et al., 2013; Wang et al., 2014). We further observed
that both ouabain and glucose oxidase-induced H2O2 stimulate
direct protein carbonylation of Pro222 and Thr224 residues of
the Na/K-ATPase α1 subunit (α1 carbonylation) in LLC-PK1
cells (Yan et al., 2013). The Pro222 and Thr224 are located
in peptide 211VDNSSLTGESEPQTR225 [UniProtKB/Swiss-Prot
No P05024 (AT1A1_PIG)]. While the α1 subunit is highly
conserved amongst human, pig, rat, and mouse (the homology
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is over 98.5%), the identified peptide is 100% identical amongst
these four species (Table 1). This peptide is located in the
actuator (A) domain of α1 subunit, and Pro222/Thr224 are
highly exposed and facing the nucleotide binding (N) domain of
the α1 subunit. Upon ouabain binding, Na/K-ATPase undergoes
conformational changes, in which the A domain is rotated to
the N domain. Structure-function analysis indicates that these
conformational changes may affect binding of the α1 subunit
to signaling molecules such as c-Src and PI3K (Yatime et al.,
2011). In addition, the peptide also contains the TGES motif
that is the anchor of A domain rotation (Yatime et al., 2011).
In immunoprecipitated α1 subunit, both ouabain and glucose
oxidase do not induce formation of advanced glycation end
products (AGEs) adducts. Like ouabain, glucose oxidase is
able to activate Na/K-ATPase signaling, leading to reduction of
transcellular22Na+ transport.
Recent studies suggest that, in biological systems, protein
carbonylation is reversible (decarbonylation) and may function
as regulatory mechanism of cell signaling (Wong et al.,
2008, 2010, 2012, 2013). We also observed a decarbonylation
mechanism, which apparently reverses the carbonylation of the
Na/K-ATPase α1 subunit induced by CTS (Yan et al., 2013).
Removal of ouabain from the culture medium clearly reverses
ouabain-mediated carbonylation; inhibition of de novo protein
synthesis as well as degradation pathways through lysosome
and proteasome does not affect this decarbonylation, which
is still poorly understood. It is possible that carbonylation
modification might stabilize the Na/K-ATPase in a certain
conformational status favoring ouabain binding to the Na/K-
ATPase α1 subunit and ouabain-Na/K-ATPase signaling, as seen
in S-glutathionylation of cysteine residue(s) of the Na/K-ATPase
(Figtree et al., 2009; Petrushanko et al., 2012). Nevertheless,
the underlying mechanism might be physiologically significant
since the carbonylation/decarbonylation process could be an
important regulator of the RPT Na/K-ATPase signaling and
sodium handling.
OXIDATIVE (CARBONYLATION)
MODIFICATION AND SALT SENSITIVITY, A
HYPOTHESIS
Based on our data and literatures, we propose that carbonylation
modification of RPT Na/K-ATPase α1 subunit has biphasic
effects. (1) Physiological and controllable α1 carbonylation
stimulates Na/K-ATPase signaling and sodium excretion,
rendering salt resistance (Figure 2A) whereas (2) prolonged
exposure to oxidant stress leads to overstimulated α1
carbonylation and desensitized Na/K-ATPase signaling, effecting
salt sensitivity (Figure 2B). First, Dahl S rats show considerably
higher basal levels of oxidative stress than R rats, and high
salt diets increase renal oxidative stresses that contribute to
salt-sensitive hypertension (Meng et al., 2002; Kitiyakara et al.,
2003; Taylor et al., 2006). Second, while high salt diets increase
TABLE 1 | Partial alignment of α1 subunit of human, pig, rat, and mouse.
SP|P05023|ATA1_HUMAN 211 CKVDNSSLTGESEP224QT226RSPDFTNENPLETR 240
SP|P05024|ATA1_PIG 209 CKVDNSSLTGESEP222QT224RSPDFTNENPLETR 238
SP|P06685|ATA1_RAT 211 CKVDNSSLTGESEP224QT226RSPDFTNENPLETR 240
SP|Q8VDN2|ATA1_MOUSE 211 CKVDNSSLTGESEP224QT226RSPDFTNENPLETR 240
Pro and Thr are shown in red.
FIGURE 2 | Illustrated hypothesis of α1 carbonylation on Na/K-ATPase signaling and sodium handling. Panel (A) shows events under physiological
stimulation and Panel (B) shows events under pathophysiological overstimulation. ROS1, CTS induced intracellular ROS generation through Na/K-ATPase signaling;
ROS2, extracellular ROS generated by glucose oxidase or other stimuli.
Frontiers in Physiology | www.frontiersin.org 5 June 2016 | Volume 7 | Article 256
Shah et al. Carbonylation Regulates Na/K-ATPase Signaling
circulating CTS, we have observed that a high salt diet (HS,
2% NaCl for 7 days) stimulates the Na/K-ATPase signaling
in isolated RPTs from Dahl R but not S rats (i.e., impaired
Na/K-ATPase signaling in S rats; Liu et al., 2011). Third, in
RPT LLC-PK1 cells, CTS- and H2O2-mediated redox-sensitive
Na/K-ATPase signaling and α1 carbonylation is involved
in this signaling process, in a feed-forwarding mechanism
(Yan et al., 2013). Fourth, high but not low concentration of
NAC is able to prevent α1 carbonylation and Na/K-ATPase
signaling (Yan et al., 2013). Even though it is still not clear of
the carbonylation/decarbonylation process, it is reasonable to
postulate that prolonged excessive α1 carbonylation (by CTS
and/or other factors) might overcome the decarbonylation
capacity, leading to desensitization or termination of the
Na/K-ATPase signaling function. This is reminiscent of the
observations in clinical trials using antioxidant supplements. The
beneficial effect of antioxidant supplements is controversial and
not seen in most clinical trials with administration of antioxidant
supplements (reviewed in Touyz, 2004; Munzel et al., 2010).
Low doses of antioxidant supplementation may be ineffective,
but high doses may be even dangerous since excess antioxidants
might become pro-oxidants if they cannot promptly be reduced
in the anti-oxidant chain (Huang et al., 2006). It appears that the
balance of the redox status, within a physiological range, may be
critical in order to maintain beneficial ROS signaling.
PERSPECTIVE
The Na/K-ATPase has recently emerged as a therapeutic target
(Aperia, 2007; Yatime et al., 2009). A clearer understanding
of the mechanisms whereby a CTS-ROS-Na/K-ATPase
signaling axis counterbalancing salt retention would have
major pathophysiological and therapeutic implications,
and further explain the progressive impairment of renal
sodium handling under excessive oxidative stresses such as
hypertension, aging, obesity, and diabetes. Impairment of
coordinated regulation of the basolateral Na/K-ATPase and
the apical NHE3 antiporter is implicated in salt-sensitive
BP changes. Furthermore, recent evidence suggests both the
Na/K-ATPase and, its adjacent signaling counterpart, c-Src to
be redox-sensitive. Although carbonylation modification of
the Na/K-ATPase is involved in the Na/K-ATPase signaling,
a more thorough mechanistic understanding is necessary.
Some pertinent questions remain to be resolved, such as the
possible effect of carbonylation on CTS binding affinity, Na/K-
ATPase conformational change, mechanisms of carbonylation/
decarbonylation, and the destiny of the carbonylated
Na/K-ATPase.
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